Go to navigation
Go to content

Welcome to AstraZeneca

As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.

Our medicines
Our responsibility
Latest features

Our continued support to their disaster response centre in Kuala Lumpur means the Red Cross can respond quickly and efficiently to emergencies in the hard-hit Asia Pacific region.
AstraZeneca’s Patrick Keohane gives keynote address at the first combined event for BioPartnering Europe and BioPartnering China.
more features
Latest news collapse
- 19 October 2009 Patients Taking VIMOVO(TM) Showed Decrease in incidence of NSAID Associated Ulcers
  AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA.
- 16 October 2009 AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™
  AstraZeneca and POZEN, Inc. today announced that they have submitted a Marketing Authorisation Application (MAA) in the European Union via the Decentralised Procedure (DCP) for VIMOVO.
more news
- previous
- - 1
  - 2
  - 3
  - 4
  - 5
- next

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.